FDA Rejects Ecstasy-Based Drug – The Wall Street Journal FDA Rejects Ecstasy-Based Drug The Wall Street JournalFDA declines to approve novel MDMA therapy to treat PTSD, with request for more trial data CNNFDA rejects ecstasy treatment for PTSD Axios